Literature DB >> 23690518

Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers.

Nicola P Klein1, Joan Bartlett, Bruce Fireman, Ali Rowhani-Rahbar, Roger Baxter.   

Abstract

BACKGROUND: During the 1990s, the United States switched from combined diphtheria, tetanus toxoids, whole-cell pertussis (DTwP) vaccines to combined acellular pertussis (DTaP) vaccines because of safety concerns. After a 2010-2011 pertussis outbreak, we sought to evaluate whether disease risk in 10 to 17 year olds differed between those who previously received DTwP from those who received DTaP.
METHODS: A case-control study among individuals born from 1994 to 1999 who received 4 pertussis-containing vaccines during the first 2 years of life at Kaiser Permanente Northern California (KPNC). We separately compared pertussis polymerase chain reaction (PCR)-positive cases with PCR-negative and KPNC-matched controls. We assessed risk of pertussis relative to vaccine type in early childhood (4 DTwPs, mixed DTwP/DTaP, or 4 DTaPs) by using conditional logistic regression stratified for calendar time and adjusted for gender, race, medical clinic, and receipt of reduced antigen content acellular pertussis (Tdap) vaccine.
RESULTS: We compared 138 PCR-positive cases with 899 PCR-negative and 54 339 KPNC-matched controls. Teenagers who had received 4 DTwPs were much less likely to be pertussis PCR-positive than those who had received 4 DTaPs (odds ratio 5.63, 95% confidence interval 2.55-12.46) or mixed DTwP/DTaP vaccines (odds ratio 3.77, 95% confidence interval 1.57-9.07). Decreasing number of DTwP doses was significantly associated with increased pertussis risk (P < .0001).
CONCLUSIONS: Teenagers who received DTwP vaccines in childhood were more protected during a pertussis outbreak than were those who received DTaP vaccines.

Entities:  

Keywords:  acellular pertussis vaccine; pertussis infection; teenagers; whole cell pertussis vaccine

Mesh:

Substances:

Year:  2013        PMID: 23690518     DOI: 10.1542/peds.2012-3836

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  59 in total

Review 1.  Strategies and new developments to control pertussis, an actual health problem.

Authors:  María Emilia Gaillard; Daniela Bottero; Griselda Moreno; Martin Rumbo; Daniela Hozbor
Journal:  Pathog Dis       Date:  2015-08-09       Impact factor: 3.166

Review 2.  Prevention of pertussis: An unresolved problem.

Authors:  Susanna Esposito; Nicola Principi
Journal:  Hum Vaccin Immunother       Date:  2018-07-24       Impact factor: 3.452

3.  A comparative clinical study to assess safety and reactogenicity of a DTwP-HepB+Hib vaccine.

Authors:  Shashank Dalvi; Prasad S Kulkarni; M A Phadke; S S More; Sanjay K Lalwani; Dipty Jain; Mamta Manglani; B S Garg; Mohan K Doibale; C T Deshmukh
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 4.  Licensed pertussis vaccines in the United States. History and current state.

Authors:  Nicola P Klein
Journal:  Hum Vaccin Immunother       Date:  2014-11-06       Impact factor: 3.452

5.  A population response analysis approach to assign class II HLA-epitope restrictions.

Authors:  Sinu Paul; Myles B C Dillon; Cecilia S Lindestam Arlehamn; Huang Huang; Mark M Davis; Denise M McKinney; Thomas Jens Scriba; John Sidney; Bjoern Peters; Alessandro Sette
Journal:  J Immunol       Date:  2015-05-06       Impact factor: 5.422

6.  Seroepidemiology of diphtheria and pertussis in Beijing, China: A cross-sectional study.

Authors:  Xiaomei Li; Meng Chen; Tiegang Zhang; Juan Li; Yang Zeng; Li Lu
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 7.  Control selection methods in recent case-control studies conducted as part of infectious disease outbreaks.

Authors:  Alison Waldram; Caoimhe McKerr; Maya Gobin; Goutam Adak; James M Stuart; Paul Cleary
Journal:  Eur J Epidemiol       Date:  2015-03-12       Impact factor: 8.082

Review 8.  Immune persistence after pertussis vaccination.

Authors:  Zhiyun Chen; Qiushui He
Journal:  Hum Vaccin Immunother       Date:  2017-01-03       Impact factor: 3.452

Review 9.  Vaccination in the elderly: what can be recommended?

Authors:  Pierre-Olivier Lang; Richard Aspinall
Journal:  Drugs Aging       Date:  2014-08       Impact factor: 3.923

Review 10.  Pertussis.

Authors:  Giovanni Gabutti; Chiara Azzari; Paolo Bonanni; Rosa Prato; Alberto E Tozzi; Alessandro Zanetti; Gianvincenzo Zuccotti
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.